Cargando…

Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results

The United Kingdom (UK) is in the third season of introducing universal paediatric influenza vaccination with a quadrivalent live attenuated influenza vaccine (LAIV). The 2015/16 season in the UK was initially dominated by influenza A(H1N1)pdm09 and then influenza of B/Victoria lineage, not containe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pebody, Richard, Warburton, Fiona, Ellis, Joanna, Andrews, Nick, Potts, Alison, Cottrell, Simon, Johnston, Jillian, Reynolds, Arlene, Gunson, Rory, Thompson, Catherine, Galiano, Monica, Robertson, Chris, Byford, Rachel, Gallagher, Naomh, Sinnathamby, Mary, Yonova, Ivelina, Pathirannehelage, Sameera, Donati, Matthew, Moore, Catherine, de Lusignan, Simon, McMenamin, Jim, Zambon, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073201/
https://www.ncbi.nlm.nih.gov/pubmed/27684603
http://dx.doi.org/10.2807/1560-7917.ES.2016.21.38.30348
_version_ 1782461526239608832
author Pebody, Richard
Warburton, Fiona
Ellis, Joanna
Andrews, Nick
Potts, Alison
Cottrell, Simon
Johnston, Jillian
Reynolds, Arlene
Gunson, Rory
Thompson, Catherine
Galiano, Monica
Robertson, Chris
Byford, Rachel
Gallagher, Naomh
Sinnathamby, Mary
Yonova, Ivelina
Pathirannehelage, Sameera
Donati, Matthew
Moore, Catherine
de Lusignan, Simon
McMenamin, Jim
Zambon, Maria
author_facet Pebody, Richard
Warburton, Fiona
Ellis, Joanna
Andrews, Nick
Potts, Alison
Cottrell, Simon
Johnston, Jillian
Reynolds, Arlene
Gunson, Rory
Thompson, Catherine
Galiano, Monica
Robertson, Chris
Byford, Rachel
Gallagher, Naomh
Sinnathamby, Mary
Yonova, Ivelina
Pathirannehelage, Sameera
Donati, Matthew
Moore, Catherine
de Lusignan, Simon
McMenamin, Jim
Zambon, Maria
author_sort Pebody, Richard
collection PubMed
description The United Kingdom (UK) is in the third season of introducing universal paediatric influenza vaccination with a quadrivalent live attenuated influenza vaccine (LAIV). The 2015/16 season in the UK was initially dominated by influenza A(H1N1)pdm09 and then influenza of B/Victoria lineage, not contained in that season’s adult trivalent inactivated influenza vaccine (IIV). Overall adjusted end-of-season vaccine effectiveness (VE) was 52.4% (95% confidence interval (CI): 41.0–61.6) against influenza-confirmed primary care consultation, 54.5% (95% CI: 41.6–64.5) against influenza A(H1N1)pdm09 and 54.2% (95% CI: 33.1–68.6) against influenza B. In 2–17 year-olds, adjusted VE for LAIV was 57.6% (95% CI: 25.1 to 76.0) against any influenza, 81.4% (95% CI: 39.6–94.3) against influenza B and 41.5% (95% CI: −8.5 to 68.5) against influenza A(H1N1)pdm09. These estimates demonstrate moderate to good levels of protection, particularly against influenza B in children, but relatively less against influenza A(H1N1)pdm09. Despite lineage mismatch in the trivalent IIV, adults younger than 65 years were still protected against influenza B. These results provide reassurance for the UK to continue its influenza immunisation programme planned for 2016/17.
format Online
Article
Text
id pubmed-5073201
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-50732012016-11-07 Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results Pebody, Richard Warburton, Fiona Ellis, Joanna Andrews, Nick Potts, Alison Cottrell, Simon Johnston, Jillian Reynolds, Arlene Gunson, Rory Thompson, Catherine Galiano, Monica Robertson, Chris Byford, Rachel Gallagher, Naomh Sinnathamby, Mary Yonova, Ivelina Pathirannehelage, Sameera Donati, Matthew Moore, Catherine de Lusignan, Simon McMenamin, Jim Zambon, Maria Euro Surveill Surveillance and Outbreak Report The United Kingdom (UK) is in the third season of introducing universal paediatric influenza vaccination with a quadrivalent live attenuated influenza vaccine (LAIV). The 2015/16 season in the UK was initially dominated by influenza A(H1N1)pdm09 and then influenza of B/Victoria lineage, not contained in that season’s adult trivalent inactivated influenza vaccine (IIV). Overall adjusted end-of-season vaccine effectiveness (VE) was 52.4% (95% confidence interval (CI): 41.0–61.6) against influenza-confirmed primary care consultation, 54.5% (95% CI: 41.6–64.5) against influenza A(H1N1)pdm09 and 54.2% (95% CI: 33.1–68.6) against influenza B. In 2–17 year-olds, adjusted VE for LAIV was 57.6% (95% CI: 25.1 to 76.0) against any influenza, 81.4% (95% CI: 39.6–94.3) against influenza B and 41.5% (95% CI: −8.5 to 68.5) against influenza A(H1N1)pdm09. These estimates demonstrate moderate to good levels of protection, particularly against influenza B in children, but relatively less against influenza A(H1N1)pdm09. Despite lineage mismatch in the trivalent IIV, adults younger than 65 years were still protected against influenza B. These results provide reassurance for the UK to continue its influenza immunisation programme planned for 2016/17. European Centre for Disease Prevention and Control (ECDC) 2016-09-22 /pmc/articles/PMC5073201/ /pubmed/27684603 http://dx.doi.org/10.2807/1560-7917.ES.2016.21.38.30348 Text en This article is copyright of The Authors, 2016. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Surveillance and Outbreak Report
Pebody, Richard
Warburton, Fiona
Ellis, Joanna
Andrews, Nick
Potts, Alison
Cottrell, Simon
Johnston, Jillian
Reynolds, Arlene
Gunson, Rory
Thompson, Catherine
Galiano, Monica
Robertson, Chris
Byford, Rachel
Gallagher, Naomh
Sinnathamby, Mary
Yonova, Ivelina
Pathirannehelage, Sameera
Donati, Matthew
Moore, Catherine
de Lusignan, Simon
McMenamin, Jim
Zambon, Maria
Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
title Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
title_full Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
title_fullStr Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
title_full_unstemmed Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
title_short Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
title_sort effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the united kingdom: 2015/16 end-of-season results
topic Surveillance and Outbreak Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073201/
https://www.ncbi.nlm.nih.gov/pubmed/27684603
http://dx.doi.org/10.2807/1560-7917.ES.2016.21.38.30348
work_keys_str_mv AT pebodyrichard effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT warburtonfiona effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT ellisjoanna effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT andrewsnick effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT pottsalison effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT cottrellsimon effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT johnstonjillian effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT reynoldsarlene effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT gunsonrory effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT thompsoncatherine effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT galianomonica effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT robertsonchris effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT byfordrachel effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT gallaghernaomh effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT sinnathambymary effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT yonovaivelina effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT pathirannehelagesameera effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT donatimatthew effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT moorecatherine effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT delusignansimon effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT mcmenaminjim effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults
AT zambonmaria effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults